Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
1651
DELISTED
Bed Bath & Beyond Inc
BBBY
| $31.9M | ﹤0.01% |
1,844,853
-70,819
| -4% | -$1.91M |
|
|
MTTR
1652
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $31.8M | ﹤0.01% |
1,683,732
+1,662,905
| +7,984% | +$27M |
|
1653
Doximity
DOCS
$4.48B
| $31.8M | ﹤0.01% |
+394,274
| New | +$28.8M |
|
|
ZUO
1654
DELISTED
Zuora, Inc.
ZUO
| $31.8M | ﹤0.01% |
1,918,997
+132,341
| +7% | +$2.23M |
|
|
CSW
1655
CSW Industrials
CSW
$5.68B
| $31.7M | ﹤0.01% |
248,420
+13,850
| +6% | +$1.72M |
|
|
SC
1656
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $31.7M | ﹤0.01% |
760,011
-54,054
| -7% | -$2.22M |
|
|
TWO
1657
Two Harbors Investment
TWO
$1.26B
| $31.7M | ﹤0.01% |
1,248,252
+132,148
| +12% | +$3.47M |
|
1658
Lantheus
LNTH
$6.58B
| $31.6M | ﹤0.01% |
1,230,183
-6,371
| -0.5% | -$166K |
|
1659
Genworth Financial
GNW
$3.77B
| $31.6M | ﹤0.01% |
8,415,347
+188,292
| +2% | +$671K |
|
1660
Coty
COTY
$2.42B
| $31.5M | ﹤0.01% |
4,005,468
+513,004
| +15% | +$4.39M |
|
1661
M/I Homes
MHO
$3.88B
| $31.3M | ﹤0.01% |
541,788
-16,521
| -3% | -$1.01M |
|
1662
Middlesex Water
MSEX
$1.11B
| $31.3M | ﹤0.01% |
304,328
-12,030
| -4% | -$1.23M |
|
1663
Microvision
MVIS
$90.2M
| $31.3M | ﹤0.01% |
188,703
+5,748
| +3% | +$1.2M |
|
|
WWE
1664
DELISTED
World Wrestling Entertainment
WWE
| $31.2M | ﹤0.01% |
554,561
+604
| +0.1% | +$31.5K |
|
1665
AstraZeneca
AZN
$245B
| $31.2M | ﹤0.01% |
264,894
+24,873
| +10% | +$2.9M |
|
1666
iShares MSCI Emerging Markets ETF
EEM
$30.6B
| – | – |
0
| – | – |
|
1667
MYR Group
MYRG
$5.2B
| $31.2M | ﹤0.01% |
313,489
+14,798
| +5% | +$1.46M |
|
1668
Northwest Bancshares
NWBI
$2.32B
| $31.1M | ﹤0.01% |
2,344,611
-58,798
| -2% | -$773K |
|
|
EPAY
1669
DELISTED
Bottomline Technologies Inc
EPAY
| $31.1M | ﹤0.01% |
791,817
+57,683
| +8% | +$2.32M |
|
1670
Sally Beauty Holdings
SBH
$1.54B
| $31.1M | ﹤0.01% |
1,845,272
+6,613
| +0.4% | +$126K |
|
|
PGRE
1671
DELISTED
Paramount Group
PGRE
| $31M | ﹤0.01% |
3,452,023
-4,666
| -0.1% | -$43.2K |
|
1672
Sphere Entertainment
SPHR
$6.25B
| $31M | ﹤0.01% |
427,007
+86,484
| +25% | +$6.48M |
|
1673
Kaiser Aluminum
KALU
$3.05B
| $31M | ﹤0.01% |
284,574
+3,592
| +1% | +$428K |
|
|
SWTX
1674
DELISTED
SpringWorks Therapeutics
SWTX
| $30.9M | ﹤0.01% |
487,436
-16,133
| -3% | -$1.24M |
|
1675
BGC Group
BGC
$5.12B
| $30.8M | ﹤0.01% |
5,919,205
+13,389
| +0.2% | +$71.1K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.